Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
GRF:BME
grifols
8,96 €
+1,63%
(+0,14) 1D
30 აპრ, 17:36:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for GRF...
Open
8,74 €
High
8,97 €
Low
8,68 €
Mkt. cap
5,52 მლრდ.
Avg. vol.
2,63 მლნ.
Volume
1,64 მლნ.
Dividend
1,67%
Quarterly dividend
0,04 €
Ex dividend date
11 აგვ. 2025
P/E ratio
15,17
52-wk high
13,70 €
52-wk low
8,01 €
EPS
0,59 €
Shares outstanding
426,13 მლნ.
No. of employees
25 ათ.
News stories
From sources across the web
Profile
Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over 30. Principally a producer of blood plasma–based products and other biopharmaceuticals, the company also operates in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, as well as clinical diagnostic technologies. Furthermore, it provides biological supplies for life-science research, clinical trials and the manufacturing of pharmaceutical and diagnostic products. It has a portfolio on four therapeutic areas: immunology, infectious diseases, pulmonology and critical care. Wikipedia
About grifols
CEONacho Abia
Employees25,3 ათ.
Founded18 ნოე. 1940
Headquarters-
Sector-
Websitegrifols.com
Last report
26 თებ. 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
-/ -EUR
Revenue / Estimate
1,98 მლრდ./ (1,96 მლრდ. est.)EUR
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
მარ. 2025
ივნ. 2025
სექ. 2025
დეკ. 2025
Revenue
1,79 მლრდ.
1,89 მლრდ.
1,87 მლრდ.
1,98 მლრდ.
Cost of goods sold
1,08 მლრდ.
1,15 მლრდ.
1,11 მლრდ.
1,28 მლრდ.
Cost of revenue
1,08 მლრდ.
1,15 მლრდ.
1,11 მლრდ.
1,28 მლრდ.
Research and development expenses
96,05 მლნ.
96,19 მლნ.
97,01 მლნ.
90,82 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
315,37 მლნ.
298,06 მლნ.
273,76 მლნ.
262,86 მლნ.
Operating expense
411,42 მლნ.
394,25 მლნ.
370,34 მლნ.
353,11 მლნ.
Total operating expenses
1,49 მლრდ.
1,54 მლრდ.
1,48 მლრდ.
1,63 მლრდ.
Operating income
293,22 მლნ.
349,54 მლნ.
381,18 მლნ.
347,38 მლნ.
Other non operating income
-
8,08 მლნ.
-
-33,00 მლნ.
EBT including unusual items
115,26 მლნ.
190,51 მლნ.
198,13 მლნ.
111,10 მლნ.
EBT excluding unusual items
134,52 მლნ.
190,51 მლნ.
227,20 მლნ.
183,10 მლნ.
Income tax expense
22,84 მლნ.
52,13 მლნ.
54,71 მლნ.
-14,68 მლნ.
Effective tax rate
19,82%
27,36%
27,61%
-13,21%
Other operating expenses
-
-
-430,00 ათ.
-570,00 ათ.
Net income
59,72 მლნ.
117,06 მლნ.
126,96 მლნ.
98,25 მლნ.
Net profit margin
3,34%
6,19%
6,81%
4,96%
Earnings per share
-
0,19
-
-
Interest and investment income
-
9,56 მლნ.
-
36,00 მლნ.
Interest expense
-153,59 მლნ.
-141,43 მლნ.
-156,07 მლნ.
-107,99 მლნ.
Net interest expenses
-153,59 მლნ.
-131,88 მლნ.
-156,07 მლნ.
-71,99 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
404,97 მლნ.
414,24 მლნ.
484,03 მლნ.
422,88 მლნ.
Gain or loss from assets sale
-
732,00 ათ.
-
2,00 მლნ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer